Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.

Scientific reports - 21 Aug 2014

Hudson Amanda L, Weir Chris, Moon Elizabeth, Harvie Rozelle, Klebe Sonja, Clarke Stephen J, Pavlakis Nick, Howell Viive M

Abstract excerpt

Mesothelioma is inherently chemo-resistant with only 50% of patients responding to the standard of care treatments, and consequently it has a very grim prognosis. The aim of this study was to establish a panel of chemo-resistant mesothelioma models with clinically relevant levels of resistance as tools for investigating chemo-resistance and identifying new treatments for mesothelioma. Chemo-resistant cell lines...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP-Binding Cassette Transporters
Share to Cell Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to Glutathione

Share to Inhibitory Concentration 50

Share to Lymphocyte Count

Share to Mesothelioma

Share to Multigene Family

Source

Open in PubMed Open full text

Identifiers

PMID: 25141917
DOI: 10.1038/srep06152
PMCID: PMC4139953

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.PMID 25141917Read ↗

Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosineSemantic proximity Read ↗

Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR InhibitionSemantic proximity Read ↗

Establishment and Histopathological Study of Patient-derived Xenograft Models and Primary Cell Lines of Epithelioid Malignant Peritoneal MesotheliomaSemantic proximity Read ↗

Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma.Semantic proximity Read ↗

Novel insights into mesothelioma biology and implications for therapySemantic proximity Read ↗

New approaches for mesothelioma: Biologics, vaccines, gene therapy, and other novel agentsSemantic proximity Read ↗

Mesotheliomas in Genetically Engineered Mice Unravel Mechanism of Mesothelial Carcinogenesis.Semantic proximity Read ↗

[Advance in molecular genetics of mesothelioma].Semantic proximity Read ↗

Mesothelioma Epidemiology, Carcinogenesis, and PathogenesisSemantic proximity Read ↗

Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.Semantic proximity Read ↗

In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti–PD-1/PD-L1 TherapiesSemantic proximity Read ↗

Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.